drugset / Trial / NCT00489372
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase I trial is studying the side effects and best dose of Se-methyl-seleno-L-cysteine in healthy adult men. Studying samples of blood, urine, and toenail clippings in the laboratory from healthy men receiving Se-methyl-seleno-L-cysteine may help doctors learn more about how Se-methyl-seleno-L-cysteine works in the body.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-03
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylselenocysteine | Other / unclassified | — | Oral |
Indications
No indication recorded.